Callos Andrew sold CYTK
March 9, 2026 · Form 4 insider transaction
Callos Andrew sold 2,582 shares of Cytokinetics, Incorporated at $60.72 per share, a transaction worth $156.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,582
Price
$60.72
Total value
$156.8K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 9, 2026
Filing dateMarch 10, 2026
Shares owned after47,858
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Sell to cover transaction to satisfy company tax withholding obligations upon vesting of RSUs.